🇺🇸 FDA
Patent

US 7888332

Hydrazide-containing CFTR inhibitor compounds and uses thereof

granted A61KA61K31/165A61K31/195

Quick answer

US patent 7888332 (Hydrazide-containing CFTR inhibitor compounds and uses thereof) held by The Regents of the University of California expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
39
CPC classes
A61K, A61K31/165, A61K31/195, A61K31/47, A61K31/7012